Petros Pharmaceuticals, Inc.·4

Dec 26, 5:07 PM ET

Boctor Fady 4

4 · Petros Pharmaceuticals, Inc. · Filed Dec 26, 2023

Insider Transaction Report

Form 4
Period: 2023-12-21
Boctor Fady
See Remarks
Transactions
  • Award

    Common Stock

    2023-12-21+49,64549,645 total
  • Award

    Stock Option (Right to Buy)

    2023-12-21+54,53354,533 total
    Exercise: $1.41Exp: 2033-12-21Common Stock (54,533 underlying)
Footnotes (1)
  • [F1]The stock options vested 50% upon the date of grant, and the remainder vests upon the achievement of certain performance goals, provided that the Reporting Person has continued to provide services to the Company through the vesting date.

Documents

1 file
  • 4
    tm2333705-6_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT